World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
23408
World Ranking
9464
National Ranking
4176

Overview

Megan S. Lim is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with a significant emphasis on pathology and forensic medicine, oncology, immunology, genetics, and molecular biology. Within these fields, their main topics of work include lymphoma diagnosis and treatment, viral-associated cancers and disorders, chronic lymphocytic leukemia research, CAR-T cell therapy research, cancer genomics and diagnostics, CNS lymphoma diagnosis and treatment, and immune cell function and interaction.

They have authored several recent papers, demonstrating engagement with hematolymphoid tumor classification, lymphoid neoplasms, and clinical oncology guidelines. Notable publications include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms (2022) published in Leukemia
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) published in Leukemia
  • International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease (2020) published in Blood Advances
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021 (2021) published in Journal of the National Comprehensive Cancer Network
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology (2020) published in PubMed

Their frequent co-authors include David C. Fajgenbaum, Kojo S.J. Elenitoba-Johnson, Sheila K. Pierson, Adam Bagg, and Frits van Rhee. These collaborations have contributed to a broad range of publications within prominent medical and oncological topics.

The primary venues where Megan S. Lim has published include:

  • Blood
  • Leukemia Research
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Leukemia

Best Publications

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • Skp2 is oncogenic and overexpressed in human cancers

    Matthias Gstaiger;Richard Jordan;Megan Lim;Charles Catzavelos

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

    Michael C. Sneller;Jin Wang;Janet K. Dale;Warren Strober

  • International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Frits Van Rhee;Peter Voorhees;Angela Dispenzieri;Alexander Fosså

  • Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

    Yael P. Mossé;Stephan D. Voss;Megan S. Lim;Delphine Rolland

  • High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.

    Noah A. Brown;Larissa V. Furtado;Bryan L. Betz;Mark J. Kiel

  • Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma

    Mark J. Kiel;Thirunavukkarasu Velusamy;Bryan L. Betz;Lili Zhao

  • Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome

    Megan S. Lim;Stephen E. Straus;Janet K. Dale;Thomas A. Fleisher

  • Activating FGFR2-RAS-BRAF mutations in ameloblastoma.

    Noah A. Brown;Delphine Cm Rolland;Jonathan B. McHugh;Helmut C. Weigelin

  • Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

    Mark J. Kiel;Thirunavukkarasu Velusamy;Delphine Rolland;Anagh A. Sahasrabuddhe

  • Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma

    Kojo S.J. Elenitoba-Johnson;Randy D. Gascoyne;Megan S. Lim;Mukesh Chhanabai

  • Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

    David A Wada;Mark E Law;Eric D Hsi;David J DiCaudo

  • Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

    Kojo S. J. Elenitoba-Johnson;Stephen D. Jenson;Robert T. Abbott;Robert A. Palais

  • The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells

    Nancy M. Joseph;Jack T. Mosher;Johanna Buchstaller;Paige Snider

  • mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion

    Jae Y. Lee;Daisuke Nakada;Omer H. Yilmaz;Zuzana Tothova

  • Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome

    Mark J. Kiel;Anagh A. Sahasrabuddhe;Delphine C.M. Rolland;Thirunavukkarasu Velusamy

  • GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.

    Tianjiao Wang;Andrew L. Feldman;David A. Wada;Ye Lu

  • Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.

    Megan S. Lim;Ann Adamson;Zhaosheng Lin;Bayardo Perez-Ordonez

  • High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.

    Aaron M. Udager;Delphine C.M. Rolland;Jonathan B. McHugh;Bryan L. Betz

Frequent Co-Authors

Kojo S.J. Elenitoba-Johnson
Kojo S.J. Elenitoba-Johnson Memorial Sloan Kettering Cancer Center
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Yoon Kyung Jeon
Yoon Kyung Jeon Seoul National University Hospital
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health
Sibrand Poppema
Sibrand Poppema Sunway University
Alexey I. Nesvizhskii
Alexey I. Nesvizhskii University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens the door to a wide range of career opportunities, especially with the flexibility of online education. Many students start their healthcare journeys through transitional programs like a medical assistant to lpn bridge program online, allowing for progressive professional growth.

For those looking to fast-track their undergraduate education, there are online biology degree programs that offer accelerated courses. These are ideal for students eager to enter the workforce or pursue graduate studies more quickly.

Nursing is another closely related field, with options like an online asn program providing foundational nursing skills that can complement a science background or serve as a standalone healthcare pathway.

Nutrition is also a growing area, with careers ranging from clinical dietetics to wellness consulting. If you’re considering this specialty, an online dietitian degree can prepare you for professional credentialing and practice.

These flexible online options make it easier than ever to begin or advance your career in the sciences and healthcare, letting you tailor your education to your specific interests and goals.

Best Scientists Citing Megan S. Lim

Trending Scientists